10.86

0.00% 0.00

Drugs Made In America Acquisition Corp (DMAA)

Overview News Price History Financials Discussions Forecast

Drugs Made In America Acquisition Corp stock is traded at $10.86, with a volume of 6,542. It is up +0.00% in the last 24 hours and up +0.18% over the past month. Drugs Made In America Acquisition Corp is a blank check company.

Previous Close:

$10.86

Open:

$10.85

24h Volume:

6,542

Relative Volume:

0.56

Market Cap:

$263.65M

Revenue:

Net Income/Loss:

$6.66M

P/E Ratio:

54.79

EPS:

0.1982

Net Cash Flow:

$-379.20K

1W Performance:

+0.09%

1M Performance:

+0.18%

6M Performance:

+3.04%

1Y Performance:

+5.44%

1-Day Range:

$10.85

$10.86

1-Week Range:

$10.85

$10.86

52-Week Range:

$10.22

$10.89

Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile

Name

Drugs Made In America Acquisition Corp

Sector

Financial (7354)

Industry

Shell Companies (308)

Phone

646-726-7074

Address

420 LEXINGTON AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

DMAA's Discussions on Twitter

Compare DMAA vs VYLR, DMII, CCXI, EVAC, BCSS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DMAA Drugs Made In America Acquisition Corp	10.86	263.65M	0	6.66M	-379.20K	0.1982
VYLR Vylor Inc.	74.41	49.65B	0	0	0	0.00
DMII Drugs Made In America Acquisition Ii Corp	10.19	649.10M	0	8.58M	-1.11M	0.134
CCXI Churchill Capital Corp Xi	10.86	604.90M	37.20M	-133.09M	-26.53M	0.0647
EVAC Eqv Ventures Acquisition Corp Ii	10.30	602.31M	0	12.80M	-714.00K	0.2184
BCSS Bain Capital Gss Investment Corp	10.22	596.85M	0	8.29M	-686.50K	0.142

Drugs Made In America Acquisition Corp Stock (DMAA) Latest News

Oct 08, 2026

DMII 8-K & SEC Filings - Yahoo Finance Australia

Oct 08, 2026

Oct 06, 2026

DMAA Stock Holds Near $10.89 as Acquisition Corp. Trades in Tight BandOutside Reversal - https://www.dars.gov.et/

Oct 06, 2026

Oct 05, 2026

DMIIU Holds Steady at $10.20 as Drugs Made In America Acquisition II Unit Trades FlatBreakout Stock Alerts - https://www.dars.gov.et/

Oct 05, 2026

Sep 18, 2026

Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times

Sep 08, 2026

Sep 03, 2026

DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACGap Down Bounce Plays - dars.gov.et

Sep 03, 2026

DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACFund Manager Survey - dars.gov.et

Sep 03, 2026

Sep 02, 2026

Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et

Sep 02, 2026

Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeQuality ETF - careplusvn.com

Sep 02, 2026

Aug 25, 2026

Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat

Aug 25, 2026

Aug 20, 2026

Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn

Aug 20, 2026

Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn

Aug 20, 2026